Active in the Chinese biotechnology and pharmaceutical markets for over two decades, Ms. Wang has held executive positions with Bayer CropScience AG, Burrill & Company and Syngenta (a Novartis spin-off). She has overseen multiple successful projects and transactions estimated at hundreds of millions of dollars.
Ms. Wang’s international experience and extensive and close network in the Chinese life science industry allowed XinTech great flexibility in tailoring multiple successful cross-border transactions, some of which were the first of their kind in China.
Ms. Wang holds an MBA from Hong Kong University of Science and Technology (HKUST), an M.A. in Economics from China Agricultural University and a BSc. in Agrochemistry from Jilin Agricultural University, China.« back